Weighted Average Number of Shares Outstanding, Basic of Chemomab Therapeutics Ltd. from 30 Jun 2021 to 31 Dec 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Chemomab Therapeutics Ltd. annual and quarterly Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Jun 2021 to 31 Dec 2024.
  • Chemomab Therapeutics Ltd. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Jun 2024 was 286,080,133, a 29% increase year-over-year.
  • Chemomab Therapeutics Ltd. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 359,048,638, a 53% increase from 2023.
  • Chemomab Therapeutics Ltd. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 234,998,859, a 3.3% increase from 2022.
  • Chemomab Therapeutics Ltd. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 227,589,288, a 9.7% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)

Chemomab Therapeutics Ltd. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 359,048,638 +124,049,779 +53% 01 Jan 2024 31 Dec 2024 20-F 04 Apr 2025 2024 FY
2023 234,998,859 +7,409,571 +3.3% 01 Jan 2023 31 Dec 2023 20-F 04 Apr 2025 2024 FY
2022 227,589,288 +20,120,638 +9.7% 01 Jan 2022 31 Dec 2022 20-F 04 Apr 2025 2024 FY
2021 207,468,650 01 Jan 2021 31 Dec 2021 20-F 28 Mar 2024 2023 FY

Chemomab Therapeutics Ltd. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 286,080,133 +64,406,003 +29% 01 Apr 2024 30 Jun 2024 6-K 21 Aug 2024 2024 Q2
Q2 2023 221,674,130 -6,499,146 -2.8% 01 Apr 2023 30 Jun 2023 6-K 21 Aug 2024 2024 Q2
Q1 2023 220,996,240 -7,094,060 -3.1% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 227,589,288 01 Oct 2022 31 Dec 2022 20-F 04 Apr 2025 2024 FY
Q3 2022 228,773,418 +817,358 +0.36% 01 Jul 2022 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 228,173,276 +11,906,283 +5.5% 01 Apr 2022 30 Jun 2022 6-K 14 Aug 2023 2023 Q2
Q1 2022 228,090,300 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q3 2021 227,956,060 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 216,266,993 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022 2022 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.